PRD Therapeutics - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Editorial infographic showing humanoid and industrial robots in a warehouse, with digital-twin mapping and key figures on commissioning, picking accuracy, operating hours and robotics orders.

Can physical AI escape the demo stage and become real industrial infrastructure?

Modal Labs has secured $750 million in Series D funding at a $15.75 billion valuation, marking a nearly 239% valuation surge in five months as demand for AI inference, GPU cloud infrastructure and autonomous coding agents accelerates, pushing the company's annualized run rate beyond $1 billion. Representative image.

Modal valuation jumps 239% as AI infrastructure demand drives $750m Series D

Salad and Go is coming back after bankruptcy, but competitors bought most of its old drive-thru network

Patient volumes rose 10% at Montrose Regional Health, so why are 77 positions disappearing?

Read More

Pharma Industry News

PRD Therapeutics begins first-in-human trial for PRD001 targeting HoFH and MASH

PRD Therapeutics initiates first-in-human clinical trial of PRD001, a novel SOAT2-selective inhibitor for HoFH and MASH, showing promise in preclinical models.

byPallavi Madhiraju

June 29, 2025

web analytics